Please assess the completion status of the following clinical trial:

Trial Title: Cochlear Implantation in Pediatric Cases of Unilateral Hearing Loss

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
i) Inclusion Criteria~1. Unilateral moderate-to-profound sensorineural hearing loss.~   1. Unaided residual hearing thresholds that yield a pure tone average (PTA) at frequencies 500 Hz, 1 kHz and 2 kHz of ≥70 dB HL in the ear to be implanted. It is possible that subjects may have hearing at other frequencies not included in this average.~  2. Hearing thresholds in the contralateral ear of ≤25 dB HL~2. Between 3 years, 6 mos and 6 years, 6 mos of age at implantation.~3. Anatomically normal cochlear nerve~4. Cochlear anatomy that is amenable to cochlear implantation as evaluated by imaging (modality at the physician's discretion) including:~   1. Normal cochlear anatomy or~  2. Incomplete Partition Type II (IP2) with or without Enlarged Vestibular Aqueduct (EVA) or~  3. EVA with normal partitioning~5. No evidence of progressive hearing loss.~6. Willing to undergo 4 week hearing aid trial as warranted based on achieving desired audibility when fitted via real ear desired sensation level (DSL) method.~7. Aided word recognition in the ear to be implanted of 30% or less as measured with Consonant Nucleus Consonant (CNC) words (50-word list)~   1. When listening with an appropriately fit hearing aid and masking applied to the contralateral ear (Turner, 2004).~  2. Aided testing will be conducted in a sound-proof booth with the participant seated 1 meter from the sound source, facing 0° azimuth. Recorded materials will be presented at 60 dB SPL.~  3. The hearing aid output will be measured using DSL targets.~8. Realistic parental expectations: a verbal acknowledgement of the potential benefits and risks, and postoperative variation in performance. For instance, cochlear implantation will not restore normal hearing.~9. Willing to obtain recommended meningitis vaccinations per CDC recommendations.~(9) Development and cognition within the normal range as measured by the Leiter-R test of nonverbal intelligence and cognitive abilities and the Bracken Basic Concept Scale -Revised.~(10) Parental commitment to study parameters including being able and willing to participate in evaluation schedule, involvement in prescribed therapy, and travel to investigational site and study-related activities.~ii) Exclusion Criteria~1. English is not primary language of the home~   1. Speech perception materials are presented in English~  2. Parental questionnaires are administered in English~2. Conductive hearing loss in either ear~3. Compromised auditory nerve~4. Ossification of the cochlea~5. Inability to participate in follow-up procedures (i.e., unwillingness, geographic location)~6. History of condition that contraindicates middle or inner ear surgery or anesthesia (i.e. otitis media refractory to treatment)~7. Case of sudden sensorineural hearing loss that has not been first evaluated by a physician

- Gender: ALL
- Minimum Age: 42 Months
- Maximum Age: 78 Months
- Healthy Volunteers: t

Study Arms:
- Cochlear Implant (Type: EXPERIMENTAL): Pediatric patients with single sided deafness will receive a cochlear implant in the ear of loss

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete